NEW YORK (GenomeWeb News) – Oxford Gene Technology today announced it has licensed its patents for detecting DNA sequence variations to Biotype Diagnostics, which will use it to develop a microarray platform.
The rights are valid for the lifetime of the patents and give Biotype certain rights with respect to SNP genotyping, OGT said in a statement. Financial and other terms of the deal were not disclosed.